Investing.com -- Shares of Allurion Technologies (NYSE: ALUR) skyrocketed by 350% following the company's announcement of its plans to initiate a clinical study aimed at optimizing muscle mass during ...

Looking further ahead, BofA lowered its iPhone sales forecasts for fiscal 2025 and 2026 to 229 million and 246 million units, ...

Novo Nordisk's phase 1b/2a clinical trial results revealed that their investigational drug, amycretin, led to an average ...

Oil prices are now fairly valued, so for the price to continue to move higher in the short term, we need to see continued ...

American Express Company reported fourth-quarter earnings that surpassed analyst expectations, but shares slipped 1.1% ...